Alcohol and Prolia (Denosumab): What You Can and Cannot Drink Safely

Does Alcohol Directly Interact with Denosumab?

No direct pharmacokinetic interaction exists between alcohol and denosumab. Denosumab is a fully human monoclonal antibody that binds RANKL, and it is not metabolized by the liver's cytochrome P450 system. Alcohol therefore does not alter its absorption, distribution, or clearance.

Why the Metabolism Pathway Matters

Most drug-alcohol interactions occur because ethanol competes for, or induces, hepatic CYP enzymes. Denosumab bypasses this system entirely. As a large-molecule biologic, it is cleared through the reticuloendothelial system via proteolytic degradation [1]. The FDA-approved prescribing information for Prolia does not list alcohol as a contraindication or precaution [2].

What the Key Trial Tells Us

The FREEDOM trial (N=7,868) enrolled postmenopausal women with osteoporosis across 214 centers in North America, Europe, and Oceania. Alcohol consumption was not an exclusion criterion, and no subgroup analysis flagged differential fracture outcomes based on reported drinking status. Over 36 months, denosumab reduced the risk of new vertebral fractures by 68% (RR 0.32, 95% CI 0.26-0.41) and hip fractures by 40% (RR 0.60, 95% CI 0.37-0.97) relative to placebo [3]. These results were achieved in a real-world population that included social drinkers.

Clinical Bottom Line

A glass of wine with dinner will not blunt Prolia's effect on RANKL signaling. The concern is not a drug interaction. It is what alcohol does to bone independently.

How Alcohol Damages Bone on Its Own

Even without a drug interaction, alcohol above moderate levels is an independent risk factor for osteoporotic fracture. Understanding this is the real clinical question for patients on denosumab.

Osteoblast Suppression

Ethanol directly suppresses osteoblast proliferation and differentiation in a dose-dependent manner. A 2005 study published in Alcoholism: Clinical and Experimental Research demonstrated that chronic alcohol exposure reduced osteoblast colony-forming units by 50% to 70% in animal models, with measurable decreases in serum osteocalcin (a marker of bone formation) in humans consuming more than 2 drinks per day [4]. Denosumab works by slowing bone resorption. If alcohol simultaneously slows bone formation, the net gain in bone density shrinks.

Dose-Response and Fracture Risk

A 2006 meta-analysis in Osteoporosis International pooled data from over 60,000 individuals and found that alcohol intake above 2 units per day was associated with a relative risk of 1.38 (95% CI 1.16-1.65) for any osteoporotic fracture compared with moderate or no intake [5]. Light to moderate drinking (0.5 to 1 drink per day) showed a slightly protective association in some cohorts, possibly through effects on inflammatory cytokines, though the mechanism remains debated.

The Threshold That Matters

The National Institute on Alcohol Abuse and Alcoholism (NIAAA) defines moderate drinking as up to 1 standard drink per day for women and up to 2 for men. One standard drink equals 14 grams of pure alcohol: 12 oz of 5% beer, 5 oz of 12% wine, or 1.5 oz of 40% spirits [6]. Staying at or below this threshold does not appear to negate the fracture-reduction benefits of denosumab therapy.

Alcohol, Calcium Absorption, and Vitamin D

Denosumab's prescribing label requires adequate calcium and vitamin D supplementation during treatment [2]. Alcohol interferes with both.

Intestinal Calcium Transport

Ethanol disrupts active calcium transport in the duodenum by downregulating the expression of TRPV6, the primary apical calcium channel in enterocytes. A controlled feeding study showed that acute alcohol ingestion (equivalent to 4 drinks) decreased fractional calcium absorption by approximately 40% over the subsequent 6-hour period [7]. For a patient on Prolia who is already at risk for hypocalcemia (the most clinically significant adverse effect of denosumab), this is not trivial.

Hepatic Vitamin D Hydroxylation

The liver converts cholecalciferol (vitamin D3) to 25-hydroxyvitamin D, the circulating storage form. Chronic alcohol use impairs this hydroxylation step. A cross-sectional analysis of NHANES III data found that adults consuming more than 14 drinks per week had 25(OH)D levels approximately 5 ng/mL lower than non-drinkers after adjusting for sun exposure, BMI, and dietary intake [8]. Since the Endocrine Society defines vitamin D insufficiency as 25(OH)D below 30 ng/mL [9], a 5 ng/mL decrement can push a borderline patient into deficient territory, exactly where hypocalcemia risk during denosumab therapy climbs.

Practical Supplementation Guidance

Patients on denosumab should take at least 1,000 mg of elemental calcium and 1,000 IU of vitamin D3 daily, per the Prolia label [2]. Those who drink regularly should separate calcium supplementation from alcohol by at least 2 hours and consider having 25(OH)D levels checked at 3-month intervals rather than annually. A target above 30 ng/mL is standard, though some bone specialists aim for 40 to 60 ng/mL in osteoporosis patients.

Fall Risk: The Overlooked Danger

Fractures require both fragile bone and a mechanical event. In osteoporosis patients, that event is almost always a fall. Alcohol is one of the most modifiable fall risk factors.

Acute Intoxication and Balance

A blood alcohol concentration (BAC) as low as 0.05% (roughly 2 drinks for a 140-lb woman consumed over one hour) measurably impairs postural sway and reaction time [10]. For a postmenopausal woman with reduced proprioception, decreased muscle mass, and possible use of other CNS-active medications (SSRIs, benzodiazepines, sleep aids), even a single extra drink can shift the probability of a fall from background noise to foreground risk.

Epidemiologic Data

The Study of Osteoporotic Fractures (SOF), a prospective cohort of 9,516 women aged 65 and older, found that women reporting 7 or more drinks per week had a 1.5-fold higher rate of non-vertebral fractures over 6 years, even after adjustment for bone mineral density [11]. The excess fracture risk was attributed primarily to falls rather than to lower BMD alone.

Combining Medications

Many patients prescribed Prolia also take medications that interact with alcohol to increase sedation: gabapentin for chronic pain, trazodone or zolpidem for insomnia, or opioids after surgical procedures. The American Geriatrics Society Beers Criteria flags alcohol use in combination with any CNS-depressant as a high-risk scenario for older adults [12]. Clinicians should screen for these combinations at each Prolia injection visit.

What "Moderate" Actually Looks Like in Practice

Guidelines define moderate intake numerically. Real-world drinking behavior is harder to measure.

Standard Drink Sizes Are Smaller Than You Think

Restaurant pours of wine average 6 to 8 oz, not the 5 oz that constitutes one standard drink. A craft IPA at 7.5% ABV in a 16 oz pint glass contains nearly 2 standard drinks, not one. Patients who report "a glass of wine with dinner" may be consuming 1.5 to 2 standard drinks without realizing it [6]. Clinicians should use visual aids or pour demonstrations during counseling.

Binge Drinking Is Particularly Harmful

The CDC defines binge drinking as 4 or more drinks for women, or 5 or more for men, within about 2 hours [13]. Even a single binge episode acutely suppresses bone formation markers (P1NP) for 24 to 48 hours and spikes cortisol, which promotes bone resorption. A patient who abstains all week and then has 5 drinks on Saturday is doing more skeletal damage than someone who has one drink each evening.

Tracking Tools

Simple drink-tracking apps (such as those recommended by the NIAAA) can help patients stay within limits. A useful clinical instruction: "Write down every drink for two weeks before your next Prolia injection, then bring the log to your appointment."

Living with Prolia: Alcohol in the Context of Broader Lifestyle

Alcohol does not exist in isolation. Patients managing osteoporosis on denosumab are balancing exercise, diet, fall prevention, and medication adherence.

Exercise Timing

Weight-bearing and resistance exercise are recommended for all osteoporosis patients [14]. Drinking within 2 hours of exercise impairs muscle protein synthesis by approximately 24% (a finding from a 2014 study in PLOS ONE using post-exercise alcohol ingestion protocols) and diminishes the osteogenic stimulus from loading [15]. Patients who exercise in the evening and then drink afterward are partially canceling the skeletal benefit of their workout.

Protein and Nutrition

Chronic alcohol consumption displaces caloric intake from protein and micronutrient-dense foods. Protein intake below 0.8 g/kg/day is associated with accelerated bone loss in older adults, per data from the Framingham Osteoporosis Study [16]. A patient on Prolia who drinks 3 glasses of wine at dinner (roughly 360 empty calories) and then eats less may be undermining bone formation from the nutritional side.

Injection Schedule Adherence

Denosumab must be administered every 6 months. Missing or delaying doses is associated with rebound vertebral fractures, sometimes multiple, due to a rapid surge in osteoclast activity [17]. Heavy drinkers have higher rates of missed medical appointments across multiple chronic conditions. The 2019 Endocrine Society clinical practice guideline on osteoporosis management emphasizes that treatment discontinuation or irregular dosing of denosumab poses a unique vertebral fracture risk not seen with bisphosphonates [18].

When to Talk to Your Doctor About Alcohol and Prolia

Not every patient needs the same conversation. Risk stratification matters.

Low-Risk Profile

A postmenopausal woman with a T-score of -2.6, no prior fractures, no CNS-active medications, and no history of alcohol use disorder who drinks 3 to 4 glasses of wine per week is unlikely to see meaningful interference with her denosumab therapy. Standard supplementation and routine monitoring suffice.

Higher-Risk Profile

A 72-year-old woman with a prior vertebral fracture, concurrent use of an SSRI and gabapentin, a 25(OH)D level of 24 ng/mL, and self-reported "social drinking" that, on closer questioning, amounts to 10 to 12 drinks per week needs a direct conversation. Her alcohol intake is likely reducing calcium absorption, lowering vitamin D, impairing balance, and increasing cortisol-mediated resorption, all while denosumab is working to preserve her remaining bone.

Questions to Ask Your Clinician

Patients should bring three data points to their next Prolia visit: a two-week drink log, their most recent 25(OH)D level, and a list of all CNS-active medications. This gives the clinician enough information to assess whether current alcohol intake is compatible with optimal treatment outcomes.

Prolia injection appointments, scheduled at fixed 6-month intervals, are natural checkpoints for this conversation. Ask your prescriber to add a serum calcium and 25(OH)D draw at each injection visit if you drink regularly.